Multi-pathway control of the proliferation versus meiotic development decision in the Caenorhabditis elegans germline
dc.contributor.author | Hansen, Dave D. | en |
dc.contributor.author | Hubbard, E. Jane Albert | en |
dc.contributor.author | Schedl, Tim | en |
dc.contributor.department | Biological Sciences | en |
dc.contributor.faculty | Faculty of Science | en |
dc.contributor.institution | University of Calgary | en |
dc.date.accessioned | 2006-08-15T16:23:18Z | |
dc.date.available | 2006-08-15T16:23:18Z | |
dc.date.issued | 2004 | |
dc.description | 2004 Elsevier Inc. All rights reserved. | en |
dc.description.abstract | An important event in the development of the germline is the initiation of meiotic development. In Caenorhabditis elegans, the conserved GLP-1/Notch signaling pathway regulates the proliferative versus meiotic entry decision, at least in part, by spatially inhibiting genes in the gld-1 and gld-2 parallel pathways, which are proposed to either inhibit proliferation and/or promote meiotic development. Mutations that cause constitutive activation of the GLP-1 pathway, or inactivation of both the gld-1 and gld-2 parallel pathways, result in a tumorous germline in which all cells are thought to be proliferative. Here, to analyze proliferation and meiotic entry in wild-type and mutant tumorous germlines, we use anti-REC-8 and anti-HIM-3 specific antibodies as markers, which under our fixation conditions, stain proliferative and meiotic cells, respectively. Using these makers in wild-type animals, we find that the border of the switch from proliferation to meiotic entry is staggered in late-larval and adult germlines. In wild-type adults, the switch occurs between 19 and 26 cell diameters from the distal end, on average. Our analysis of mutants reveals that tumorous germlines that form when GLP-1 is constitutively active are completely proliferative, while tumors due to inactivation of the gld-1 and gld-2 pathways show evidence of meiotic entry. Genetic and time course studies suggest that a third pathway may exist, parallel to the GLD-1 and GLD-2 pathways, that promotes meiotic development. | en |
dc.description.refereed | yes | en |
dc.format.extent | 918865 bytes | |
dc.format.mimetype | application/pdf | |
dc.identifier.citation | Dave Hansen, E. Jane Albert Hubbard,Tim Schedl "Multi-pathway control of the proliferation versus meiotic development decision in the Caenorhabditis elegans germline" Developmental Biology 268 (2004) 342–357 | en |
dc.identifier.doi | http://dx.doi.org/10.11575/PRISM/35125 | |
dc.identifier.issn | 0012-1606 | |
dc.identifier.uri | http://hdl.handle.net/1880/43437 | |
dc.language.iso | en | en |
dc.publisher | Elsevier | en |
dc.publisher.url | http://www.elsevier.com/wps/find/journaldescription.cws_home/622816/description#description | |
dc.subject | Biology | en |
dc.subject.other | Germline development | en |
dc.subject.other | Proliferation | en |
dc.subject.other | Meiotic entry | en |
dc.subject.other | Germline tumor | en |
dc.subject.other | GLP-1/Notch | en |
dc.subject.other | gld-1 | en |
dc.subject.other | gld-2 | en |
dc.subject.other | nos-3 | en |
dc.title | Multi-pathway control of the proliferation versus meiotic development decision in the Caenorhabditis elegans germline | en |
dc.type | journal article |